A cross-tabulation analysis was performed to evaluate the relationship between anti-HBc IgG status and biopsy categories (including cirrhosis, hepatitis, hepatitis with PBC, and AIH with steatosis) and treatment response. This evidence concerns the gene KRT88P and hepatitis A virus infection.